![Henry Hoppe](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Henry Hoppe
Corporate Officer/Principal chez Xenetic Biosciences (UK) Ltd.
Postes actifs de Henry Hoppe
Sociétés | Poste | Début | Fin |
---|---|---|---|
Xenetic Biosciences (UK) Ltd.
![]() Xenetic Biosciences (UK) Ltd. Pharmaceuticals: MajorHealth Technology Xenetic Biosciences (UK) Ltd. is engaged in the development of drug and vaccine delivery systems and proprietary products in the fields of protein drugs, vaccines and oncology. It provides specialist delivery solutions to improve the efficacy and performance of drugs and vaccines in a number of key medical areas including oncology. The company's product pipeline includes polyxen, imuxen and oncohist. Xenetic Biosciences was founded by Gregory Gregoriadis on June 24, 1996 and is headquartered in London, the United Kingdom. | Corporate Officer/Principal | 14/05/2012 | - |
Historique de carrière de Henry Hoppe
Formation de Henry Hoppe
Massachusetts Institute of Technology | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 2 |
Royaume-Uni | 2 |
Opérationnelle
Corporate Officer/Principal | 1 |
Doctorate Degree | 1 |
Undergraduate Degree | 1 |
Sectorielle
Finance | 2 |
Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
Xenetic Biosciences (UK) Ltd.
![]() Xenetic Biosciences (UK) Ltd. Pharmaceuticals: MajorHealth Technology Xenetic Biosciences (UK) Ltd. is engaged in the development of drug and vaccine delivery systems and proprietary products in the fields of protein drugs, vaccines and oncology. It provides specialist delivery solutions to improve the efficacy and performance of drugs and vaccines in a number of key medical areas including oncology. The company's product pipeline includes polyxen, imuxen and oncohist. Xenetic Biosciences was founded by Gregory Gregoriadis on June 24, 1996 and is headquartered in London, the United Kingdom. | Health Technology |
- Bourse
- Insiders
- Henry Hoppe
- Expérience